Immage Biotherapeutics Stock Forecast - Simple Moving Average
| IMMG Stock | USD 0.0001 0.00 0.00% |
Immage Stock outlook is based on your current time horizon. We recommend always using this module together with an analysis of Immage Biotherapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 25th of January 2026 the value of rsi of Immage Biotherapeutics' share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Immage Biotherapeutics hype-based prediction, you can estimate the value of Immage Biotherapeutics Corp from the perspective of Immage Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Immage Biotherapeutics Corp on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00. Immage Biotherapeutics after-hype prediction price | USD 1.0E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Immage Biotherapeutics to cross-verify your projections. Immage Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Immage price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Immage using various technical indicators. When you analyze Immage charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Immage Biotherapeutics Simple Moving Average Price Forecast For the 26th of January
Given 90 days horizon, the Simple Moving Average forecasted value of Immage Biotherapeutics Corp on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.Please note that although there have been many attempts to predict Immage Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Immage Biotherapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Immage Biotherapeutics Stock Forecast Pattern
| Backtest Immage Biotherapeutics | Immage Biotherapeutics Price Prediction | Buy or Sell Advice |
Immage Biotherapeutics Forecasted Value
In the context of forecasting Immage Biotherapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Immage Biotherapeutics' downside and upside margins for the forecasting period are 0.0001 and 0.0001, respectively. We have considered Immage Biotherapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Immage Biotherapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Immage Biotherapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | -9.223372036854776E14 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Immage Biotherapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Immage Biotherapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Immage Biotherapeutics After-Hype Price Density Analysis
As far as predicting the price of Immage Biotherapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Immage Biotherapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Immage Biotherapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Immage Biotherapeutics Estimiated After-Hype Price Volatility
In the context of predicting Immage Biotherapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Immage Biotherapeutics' historical news coverage. Immage Biotherapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Immage Biotherapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Immage Biotherapeutics is very steady at this time. Analysis and calculation of next after-hype price of Immage Biotherapeutics is based on 3 months time horizon.
Immage Biotherapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Immage Biotherapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Immage Biotherapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Immage Biotherapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0001 | 0.0001 | 0.00 |
|
Immage Biotherapeutics Hype Timeline
Immage Biotherapeutics is currently traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Immage is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Immage Biotherapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 70.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Immage Biotherapeutics recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. The firm had 273:1 split on the 13th of February 2015. Given the investment horizon of 90 days the next expected press release will be uncertain. Check out Historical Fundamental Analysis of Immage Biotherapeutics to cross-verify your projections.Immage Biotherapeutics Related Hype Analysis
Having access to credible news sources related to Immage Biotherapeutics' direct competition is more important than ever and may enhance your ability to predict Immage Biotherapeutics' future price movements. Getting to know how Immage Biotherapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Immage Biotherapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BITCF | First BITCoin Capital | 0.00 | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TLGN | Totally Green | 0.00 | 0 per month | 0.00 | 0.17 | 0.00 | 0.00 | 100.00 | |
| CHFI | China Finance | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RNBI | Rainbow International Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EURI | Agrieuro Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BLPFF | BLOK Technologies | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| WNCG | Wyncrest Group | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AXTG | Axis Technologies Group | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| XYNH | Xynergy Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIVX | CTR Investments Consulting | 0.00 | 0 per month | 13.47 | 0.08 | 50.00 | (33.33) | 150.00 |
Other Forecasting Options for Immage Biotherapeutics
For every potential investor in Immage, whether a beginner or expert, Immage Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Immage Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Immage. Basic forecasting techniques help filter out the noise by identifying Immage Biotherapeutics' price trends.Immage Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immage Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Immage Biotherapeutics could also be used in its relative valuation, which is a method of valuing Immage Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Immage Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Immage Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immage Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Immage Biotherapeutics stock market strength indicators, traders can identify Immage Biotherapeutics Corp entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Story Coverage note for Immage Biotherapeutics
The number of cover stories for Immage Biotherapeutics depends on current market conditions and Immage Biotherapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Immage Biotherapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Immage Biotherapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Check out Historical Fundamental Analysis of Immage Biotherapeutics to cross-verify your projections. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immage Biotherapeutics. If investors know Immage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immage Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immage Biotherapeutics is measured differently than its book value, which is the value of Immage that is recorded on the company's balance sheet. Investors also form their own opinion of Immage Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Immage Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immage Biotherapeutics' market value can be influenced by many factors that don't directly affect Immage Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immage Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immage Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immage Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.